Objective: To determine whether mutants of Streptococcus pneumoniae that are deficient in pneumococcal surface protein A (PspA), pneumococcal surface antigen A (PsaA), or pneumolysin (Ply) are less virulent and less likely to penetrate the round window membrane (RWM).
B
ACTERIAL OTITIS MEDIA (OM) is one of the most common diseases of childhood throughout the world. Otitis media can lead to inner ear disease and acquired hearing loss. Functional studies [1] [2] [3] of children and adults have demonstrated a high-frequency hearing loss secondary to OM, and histopathologic evidence 4 of inner ear damage in patients with chronic OM has been reported. Although the incidence of pneumococcal OM has decreased since the introduction of pneumococcal conjugate vaccines, Streptococcus pneumoniae remains 1 of the major pathogens in OM. Animal experiments have demonstrated that inflammatory mediators, 5 bacterial products, 6 and whole bacteria 7 pass from the middle ear through the round window membrane (RWM) into the inner ears, resulting in inner ear damage.
Several proteins have been shown to contribute to the pathogenesis of S pneumoniae in different systemic and invasive diseases, including OM. The function of these proteins seems to facilitate significant aspects of pneumococcal colonization and invasion; among these are pneumococcal surface protein A (PspA), pneumococcal surface antigen A (PsaA), and pneumolysin (Ply). These and other proteins and combinations of these proteins are under investigation for use as vaccine candidates against pneumococcal infection. 8 It has been recently shown that live attenuated strains of S pneumoniae that contain a combination of deletions in the Ply and PspA genes induce systemic and mucosal protection in mice from challenge with a high dose of the parent S pneumoniae strain. 9 Pneumococcal surface protein A is a membrane-bound protein that can prevent activation of complement by pneumococci 10, 11 and is capable of binding to and preventing the killing of S pneumoniae by apolactoferrin. 12 Pneumococcal surface protein A is a manganese and zinc transporter involved in growth and virulence. 13 Pneumolysin is a cholesterol-binding pore-forming protein with cytotoxic and complement activation properties.
14 Higher levels of antibodies to PsaA and Ply in children are associated with lower risk of bacterial carriage and OM. 15 Immunization with PspA prevented acute OM in an experimental rat model of S pneumoniae OM. 16 The goal of this study was to define the various roles of virulence proteins PspA, PsaA, and Ply in the pathogenicity of S pneumoniae in the middle ear and their effects on the structure and permeability of the RWM using the chinchilla model. We tested the hypothesis that S pneumoniae mutants deficient in PspA, PsaA, or Ply inoculated in the middle ear cavity may be less likely to penetrate the RWM compared with the wild-type parent strain.
METHODS

BACTERIAL STRAINS AND GROWTH CONDITIONS
The pneumococcal strains used in this study were S pneumoniae serotype 2 strain D39 and its isogenic Ply The bacterial strains were stored in a 10% glycerin freezing solution at −80°C. After growing the colonies overnight in THB or blood agar, the bacteria were transferred to THB and incubated in a 37°C water bath until in the log phase. They were then centrifuged at 2000g for 15 minutes, the broth was discarded, and the bacteria were suspended in 0.15-mol/L phosphate-buffered saline; optical densities at 660 nm were measured. Based on the specific strain, estimated concentrations were determined and the solution was diluted to the desired concentration in phosphate-buffered saline. Plating 10-fold dilutions onto blood agar plates, incubating overnight at 37°C in a 5% to 10% carbon dioxide environment, and counting viable cells confirmed the actual concentration.
ANIMALS AND HISTOLOGIC ANALYSIS
All animals were housed and fed under standard conditions at our institutional animal care facility. Experiments were performed on young chinchillas (weight, 250-350 g) with normal external auditory canals and tympanic membranes. The care and use of animals were approved by the Institutional Animal Care and Use Committee of the University of Minnesota. All animals were anesthetized before intrabullar inoculations with a combination of ketamine hydrochloride (100 mg/kg) and acepromazine (10 mg/kg). Animals were killed by an overdose of sodium pentobarbital.
A total of 41 chinchillas were given bilateral intrabullar inoculations of 0.5 mL of approximately 10 5 , 10, 6 or 10 7 colonyforming units of S pneumoniae serotype 2 strain D39 (n=15) or its isogenic PspA − (n=10), PsaA − (n=7), or Ply − (n=9) mutants (Table) . Animals were killed 2 days after inoculation. Bullae were removed and the cochlea were perfused via the apex and oval window with 2% glutaraldehyde in 0.1-mol/L phosphate buffer, pH 7.4. Fixation was continued by emersion for 2 hours. Samples were decalcified in 10% EDTA on a rotator in a cold room for 3 days. EDTA was changed daily. Samples were washed in buffer and postfixed in 1% osmium tetroxide in buffer for 1 hour. They were washed again in buffer, dehydrated in a graded series of ethanol followed by propylene oxide, and embedded in epoxy resin. Samples were cut at a thickness of 1 µm and stained with toluidine blue for light microscopic assessment. For electron microscopy, samples were cut at a thickness of 20 nm, stained with uranyl acetate and lead citrate, and examined by electron microscopy.
RESULTS
Actual concentrations of bacteria used for inoculation of the animals ranged from 8.0ϫ10
5 to 3.4ϫ10 7 for the wildtype strain, 3.0ϫ10 5 to 8.0ϫ10 7 for PspA − , 6.0ϫ10 5 to 5.0ϫ10 6 for PsaA − , and 2.0ϫ10 6 to 6.0ϫ10 7 for Ply − mutant strains. The wild-type strain of S pneumoniae was more virulent than mutant bacterial strains; of the 15 wild-type S pneumoniae-inoculated animals, 3 died and 3 were ill and had to be killed 1 day after inoculation. The Table lists the type of middle ear fluid, RWM inflammatory cell infiltration, and injury for all groups. In 7 of the 12 wildtype S pneumoniae-inoculated animals, bacteria penetrated the RWM and passed into the adjacent scala tympani (Figure 1 and Figure 2) . The Ply-deficient mutant seemed to be highly virulent and produced pathologic changes similar to those of the wild-type strain. In the Ply − -inoculated animals, bacteria were observed in the RWM and adjacent scala tympani in most animals (7 of 9 animals) (Figure 3) .
The PspA − and PsaA − mutants were much less virulent compared with the wild-type and Ply − strains. Of the 10 animals inoculated with the PspA − mutant, only 1 died (9 were included for study), and none of the 7 animals died after inoculation with the PsaA − mutant. No bacteria were observed inside the RWM or scala tympani after inoculation of the PspA − ( Figure 4A) or PsaA − ( Figure 4B ) mutants. Inflammatory cell infiltration in the RWM was observed in 2 of the PspA − -inoculated animals and in 2 animals inoculated with PsaA − .
COMMENT
The pathogenesis of OM is multifactorial with host defenses, virulence characteristics of bacteria, and environmental and genetic factors playing important roles. Streptococcus pneumoniae is a common pathogen in acute OM. Widespread use of oral antibiotics has resulted in an alarming increase of antibiotic-resistant bacterial strains, increasing the potential for labyrinthitis, tympanogenic meningitis, hearing loss, and other complications of OM. Pneumococcal proteins facilitate significant aspects of pneumococcal colonization and invasion and can, therefore, serve as potential components for new vaccines. In this article, we studied the effects of the Ply − , PspA − , and PsaA − mutants of S pneumoniae compared with the wildtype strain using a chinchilla model of OM. Several S pneumoniae proteins interact with complement components in vitro, including PspA, PsaA, and Ply.
Although Ply− mutants have been shown to be less virulent in various areas, including the lung and blood, we found the Ply− mutant, like its parent wild-type strain, able to colonize the middle ear and, contrary to PspA − and PsaA − mutants, penetrate and pass through the RWM into the scala tympani of the inner ear. Our findings support those of other investigators who showed the cell wall to be the most important contributor to pneumococcal pathogenicity in OM, with at most a modest additional effect of pneumolysin. 17 However, our study involved high-dose bacterial infection for a short duration in the middle ear, which may affect the clearance and pathogenicity of the mutant strains.
We found PspA-and PsaA-deficient strains to be much less virulent than the wild-type or Ply − strains. Furthermore, they were not observed to penetrate through the epithelial layer of the RWM. Pneumococcal surface protein A is involved in interactions with the host complement system, reducing complement-mediated clearance and phagocytosis. 10, 11 Another function of PspA in pneumococcal virulence is the prevention of the bactericidal effect of the host molecule, lactoferrin. Lactoferrin is an iron storage glycoprotein that is predominantly found in mucosal secretions, including middle ear effusions. 18 The apo form of lactoferrin (apoL) is the form that is bactericidal against pneumococci, and PspA binding to apoL presumably protects pneumococci against its bactericidal effects. 12 Because of the high concentrations of apoL in secretions, the process most likely takes place at the mucosal surface and facilitates colonization and carriage of S pneumoniae. 19 It has been reported 20 that resistance to pneumococcal carriage is dependent on mucosal rather than systemic immunity.
Immunization with the PspA protein prevented acute OM in an experimental model of S pneumoniae OM. 16, 21 Pneumococcal surface protein A is known to be a surfacebinding protein; however, debate continues regarding its role as a pneumococcal adhesion molecule. 22 The low virulence of PsaA − strains has been attributed to their ability to transport manganese. 13, 23 The PsaA − mutant of S pneumoniae has been shown to be attenuated in the middle ears of gerbils. 23 Pneumococcal surface protein A plays a significant role in pneumococcal carriage, and intranasal immunization with a cholera toxin B subunit-PsaA fusion protein was shown to protect mice against colonization with S pneumoniae. 24 It has been shown that a low risk of nasal pharyngeal carriage progresses to acute OM in children who have a high titer of naturally developed serum and mucosal anti-PsaA antibodies. 15 Immunizations with PspA and PsaA proteins have been shown to offer better protection against nasal carriage in mice than immunization with either protein alone. 25 Although the roles of pneumococcal proteins PspA and PsaA are different, neither mutant penetrated the RWM, supporting their potential use as vaccine candidates for OM and making them extremely effective in preventing RWM and inner ear damage. Furthermore, their serotype independence and their theoretical advantage of inducing antibodies in children too young to mount effective antibody responses against polysaccharide antigens require further studies regarding these bacterial proteins and their possible use in prevention and treatment of OM and its complications. 
